NC Company Announces Planned Trial on New Experimental Ebola Drug
Published at
AlexRaths/iStockphoto/Thinkstock(DURHAM, N.C.) — Chimerix, Inc. announced on Monday that it had provided the drug brincidofovir for potential use in patients with Ebola.
The drug was granted Emergency Investigational New drug Applications by the U.S. Food and Drug Administration, the North Carolina-based company said. “Chimerix is committed to working with global health organizations and government agencies in the fight against the Ebola virus outbreak,” M. Michelle Berrey, president and CEO of Chimerix said in a statement.
Chimerix says it is working with the FDA to, “finalize a clinical trial protocol this week to assess the safety, tolerability, and efficacy of brincidofovir” in patients confirmed to have Ebola.
More ABC news videos | ABC Entertainment News
Copyright 2014 ABC News Radio